Literature DB >> 1605132

Effects of "kyushin", a drug containing toad venom, on experimental congestive heart failure in rabbits.

S Morishita1, M Shoji, Y Oguni, C Ito, K Noguchi, M Sakanashi.   

Abstract

Effects of "Kyushin" (KY-2), a drug containing toad venom, on a low-output-type heart failure model produced in rabbits by protease treatment on the left ventricular anterior wall, were examined. Heart rate, aortic blood flow (AoF), left ventricular systolic pressure (LVP) and maximal rate of rise of LVP (max dP/dt) in this model were maintained at lower levels than those in normal rabbits, while left ventricular end-diastolic pressure (LVEDP) and systemic vascular resistance (SVR) were maintained at higher levels, and the mean blood pressure (MBP) was at a normal level. KY-2 was administered intraduodenally to the animal. KY-2 improved heart failure state by increasing the AoF, LVP and max dP/dt, and by decreasing the LVEDP and SVR without a significant change in MBP. These results suggest that the beneficial effects of KY-2 on this heart failure model originate from their cardiotonic activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1605132     DOI: 10.1142/S0192415X92000096

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  2 in total

1.  Bufadienolides from Venenum Bufonis Inhibit mTOR-Mediated Cyclin D1 and Retinoblastoma Protein Leading to Arrest of Cell Cycle in Cancer Cells.

Authors:  Huamei Chang; Juan Li; Yajun Cao; Tiantian Liu; Suofang Shi; Wenxing Chen
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-11       Impact factor: 2.629

Review 2.  Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review.

Authors:  Mohammad Amjad Hossain; Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2022-01-19       Impact factor: 5.735

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.